Holdings of VIP Health Care Portfolio
Variable Insurance Products Fund IV · Original filing · Compare with another fund · Report an error
- Net assets
- 1.2B $ including 1.1B $ in equities, 96.8 %
- Positions
- 104 in 10 countries
- Top ten
- 38.4 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 75,000 | 90M $ | 7.78 % |
| 2 | Danaher Corp | 390,000 | 74.3M $ | 6.42 % |
| 3 | Thermo Fisher Scientific Inc | 116,000 | 58.2M $ | 5.03 % |
| 4 | Johnson & Johnson | 208,000 | 52.8M $ | 4.57 % |
| 5 | UnitedHealth Group Inc | 108,000 | 44.9M $ | 3.88 % |
| 6 | AbbVie Inc | 128,000 | 32.2M $ | 2.79 % |
| 7 | Ascendis Pharma A/S | 100,000 | 26.7M $ | 2.31 % |
| 8 | ALNYLAM PHARMACEUTICALS INC | 75,400 | 22.7M $ | 1.96 % |
| 9 | Merck & Co Inc | 170,000 | 21.8M $ | 1.89 % |
| 10 | Argenx SE | 22,040 | 20.4M $ | 1.77 % |
| 11 | Gilead Sciences Inc | 160,000 | 20.2M $ | 1.75 % |
| 12 | Boston Scientific Corp | 460,000 | 19.6M $ | 1.70 % |
| 13 | NATERA INC | 69,500 | 18.9M $ | 1.63 % |
| 14 | UCB SA | 62,800 | 18.8M $ | 1.63 % |
| 15 | Agilent Technologies Inc | 133,100 | 17.7M $ | 1.53 % |
| 16 | MODERNA INC | 250,000 | 17.5M $ | 1.51 % |
| 17 | West Pharmaceutical Services Inc | 42,819 | 15.4M $ | 1.33 % |
| 18 | VIATRIS INC | 950,000 | 15.1M $ | 1.30 % |
| 19 | ORUKA THERAPEUTICS INC | 149,300 | 14.2M $ | 1.23 % |
| 20 | REVOLUTION MEDICINES INC | 75,000 | 14M $ | 1.21 % |
| 21 | GUARDANT HEALTH INC | 92,000 | 13.8M $ | 1.19 % |
| 22 | VAXCYTE INC | 233,100 | 13.6M $ | 1.17 % |
| 23 | COGENT BIOSCIENCES INC | 336,100 | 13M $ | 1.12 % |
| 24 | CVS Health Corp | 125,000 | 12.9M $ | 1.12 % |
| 25 | Veracyte Inc | 218,000 | 12.8M $ | 1.11 % |
| 26 | Enliven Therapeutics Inc | 251,725 | 12.8M $ | 1.10 % |
| 27 | 10X Genomics Inc | 323,600 | 12.4M $ | 1.07 % |
| 28 | Repligen Corp | 90,000 | 12.3M $ | 1.06 % |
| 29 | Xenon Pharmaceuticals Inc | 200,000 | 12.1M $ | 1.04 % |
| 30 | CARIS LIFE SCIENCES INC | 654,409 | 11.7M $ | 1.01 % |
| 31 | PRIVIA HEALTH GROUP INC | 450,000 | 11.6M $ | 1.00 % |
| 32 | Spyre Therapeutics Inc | 128,000 | 11.4M $ | 0.98 % |
| 33 | Bio-Techne Corp | 160,000 | 11.3M $ | 0.98 % |
| 34 | ROYALTY PHARMA PLC | 200,000 | 11.2M $ | 0.97 % |
| 35 | JAZZ PHARMACEUTICALS PLC | 46,000 | 11.1M $ | 0.96 % |
| 36 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 170,100 | 10.9M $ | 0.94 % |
| 37 | LEGEND BIOTECH CORP | 362,700 | 10.5M $ | 0.91 % |
| 38 | KYMERA THERAPEUTICS INC | 85,958 | 9.9M $ | 0.85 % |
| 39 | Bruker Corp | 163,508 | 9.8M $ | 0.85 % |
| 40 | Insmed Inc | 90,000 | 9.6M $ | 0.83 % |
| 41 | LIFESTANCE HEALTH GROUP INC | 861,900 | 9.2M $ | 0.80 % |
| 42 | Praxis Precision Medicines Inc | 26,000 | 8.7M $ | 0.75 % |
| 43 | Roche Holding AG | 20,000 | 8.2M $ | 0.71 % |
| 44 | Axsome Therapeutics Inc | 33,000 | 8.1M $ | 0.70 % |
| 45 | Roivant Sciences Ltd | 228,000 | 8.1M $ | 0.70 % |
| 46 | Relay Therapeutics Inc | 376,000 | 7M $ | 0.61 % |
| 47 | BRIGHTSPRING HEALTH SERVICES INC | 100,000 | 7M $ | 0.60 % |
| 48 | Elevance Health Inc | 18,000 | 7M $ | 0.60 % |
| 49 | ALIGNMENT HEALTHCARE INC | 285,000 | 6.8M $ | 0.59 % |
| 50 | Crinetics Pharmaceuticals Inc | 176,000 | 6.6M $ | 0.57 % |
| 51 | CG ONCOLOGY INC | 90,000 | 6.4M $ | 0.55 % |
| 52 | Edwards Lifesciences Corp | 69,000 | 6.2M $ | 0.54 % |
| 53 | Sartorius Stedim Biotech | 30,000 | 6.2M $ | 0.54 % |
| 54 | Cencora Inc | 21,800 | 6.2M $ | 0.53 % |
| 55 | Biogen Inc | 28,000 | 6M $ | 0.52 % |
| 56 | TRAVERE THERAPEUTICS INC | 106,000 | 6M $ | 0.52 % |
| 57 | Mineralys Therapeutics Inc | 218,000 | 5.9M $ | 0.51 % |
| 58 | Disc Medicine Inc | 80,000 | 5.9M $ | 0.51 % |
| 59 | Dianthus Therapeutics Inc | 59,610 | 5.8M $ | 0.50 % |
| 60 | MBX BIOSCIENCES INC | 105,000 | 5.8M $ | 0.50 % |
| 61 | Medline Inc | 145,000 | 5.7M $ | 0.49 % |
| 62 | HeartFlow Inc | 185,000 | 5.4M $ | 0.47 % |
| 63 | VERADERMICS INC | 42,000 | 5.2M $ | 0.45 % |
| 64 | VIRIDIAN THERAPEUTICS INC | 280,000 | 5.1M $ | 0.44 % |
| 65 | STRUCTURE THERAPEUTICS INC | 95,000 | 5.1M $ | 0.44 % |
| 66 | MIRUM PHARMACEUTICALS INC | 42,800 | 5M $ | 0.43 % |
| 67 | TWIST BIOSCIENCE CORP | 48,000 | 4.9M $ | 0.43 % |
| 68 | NEWAMSTERDAM PHARMA COMPANY NV | 140,000 | 4.7M $ | 0.41 % |
| 69 | ZENAS BIOPHARMA INC | 185,000 | 4.7M $ | 0.41 % |
| 70 | AMYLYX PHARMACEUTICALS INC | 260,000 | 4.7M $ | 0.40 % |
| 71 | Pharvaris NV | 128,000 | 4.4M $ | 0.38 % |
| 72 | Scholar Rock Holding Corp | 80,000 | 4.4M $ | 0.38 % |
| 73 | BEONE MEDICINES LTD | 15,000 | 4.3M $ | 0.37 % |
| 74 | Kestra Medical Technologies Ltd | 164,400 | 4.2M $ | 0.36 % |
| 75 | Intuitive Surgical Inc | 10,500 | 4.2M $ | 0.36 % |
| 76 | ALUMIS INC | 145,911 | 4.1M $ | 0.36 % |
| 77 | Viking Therapeutics Inc | 100,000 | 3.9M $ | 0.34 % |
| 78 | Stoke Therapeutics Inc | 118,000 | 3.9M $ | 0.33 % |
| 79 | Illumina Inc | 21,800 | 3.8M $ | 0.33 % |
| 80 | IRhythm Holdings Inc | 32,000 | 3.8M $ | 0.33 % |
| 81 | Olema Pharmaceuticals Inc | 285,000 | 3.6M $ | 0.31 % |
| 82 | JADE BIOSCIENCES INC | 153,646 | 3.4M $ | 0.30 % |
| 83 | Trevi Therapeutics Inc | 180,000 | 3.4M $ | 0.29 % |
| 84 | CYTOMX THERAPEUTICS INC | 860,000 | 3.2M $ | 0.28 % |
| 85 | DAMORA THERAPEUTICS INC | 118,000 | 3.1M $ | 0.27 % |
| 86 | Immunocore Holdings PLC | 84,000 | 2.7M $ | 0.23 % |
| 87 | GMR Solutions Inc | 160,000 | 2.5M $ | 0.21 % |
| 88 | Edgewise Therapeutics Inc | 54,000 | 2.2M $ | 0.19 % |
| 89 | Summit Therapeutics Inc | 145,000 | 2.1M $ | 0.18 % |
| 90 | WAYSTAR HOLDING CORP | 90,000 | 1.8M $ | 0.16 % |
| 91 | First Tracks Biotherapeutics Inc | 80,000 | 1.6M $ | 0.14 % |
| 92 | TYRA BIOSCIENCES INC | 50,000 | 1.6M $ | 0.14 % |
| 93 | Alamar Biosciences Inc | 56,000 | 1.5M $ | 0.13 % |
| 94 | Contineum Therapeutics Inc | 80,000 | 1.3M $ | 0.11 % |
| 95 | Insulet Corp | 8,000 | 1.2M $ | 0.11 % |
| 96 | OUTSET MEDICAL INC | 280,000 | 1.2M $ | 0.10 % |
| 97 | Annexon Inc | 200,000 | 1.1M $ | 0.10 % |
| 98 | Upstream Bio Inc | 145,000 | 1M $ | 0.09 % |
| 99 | OCULAR THERAPEUTIX INC | 83,621 | 821.2K $ | 0.07 % |
| 100 | HEMAB THERAPEUTICS HOLDINGS INC | 11,500 | 422.4K $ | 0.04 % |
Sector breakdown
- Health care 55.8 %
- Unattributed 44.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 97.0 %
- EUR 2.2 %
- CHF 0.7 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.9 %
- Netherlands 2.6 %
- Denmark 2.4 %
- Belgium 1.7 %
- Bermuda 1.1 %
- Canada 1.1 %
- Ireland 1.0 %
- Cayman Islands 0.9 %
- Switzerland 0.7 %
- France 0.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 92 | 983.6M $ | 87.90 % |
| 2 | Netherlands | 3 | 29.6M $ | 2.65 % |
| 3 | Denmark | 1 | 26.7M $ | 2.38 % |
| 4 | Belgium | 1 | 18.8M $ | 1.68 % |
| 5 | Bermuda | 2 | 12.3M $ | 1.09 % |
| 6 | Canada | 1 | 12.1M $ | 1.08 % |
| 7 | Ireland | 1 | 11.1M $ | 0.99 % |
| 8 | Cayman Islands | 1 | 10.5M $ | 0.94 % |
| 9 | Switzerland | 1 | 8.2M $ | 0.74 % |
| 10 | France | 1 | 6.2M $ | 0.56 % |
Cite this page
Titelia. "Holdings of VIP Health Care Portfolio". https://titelia.com/en/funds/S000007742